Most read article(s)

Open Access
CXCR4/ACKR3 Phosphorylation and Recruitment of Interacting Proteins: Key Mechanisms Regulating Their Functional Status
Amos Fumagalli, Aurélien Zarca, Maria Neves, Birgit Caspar, Stephen J. Hill, Federico Mayor, Martine J. Smit and Philippe Marin

Molecular Pharmacology December 2019, 96 (6) 794-808; DOI: https://doi.org/10.1124/mol.118.115360
You have access
Heterozygous Deficiency of Manganese Superoxide Dismutase in Mice (Mn-SOD^+/-): A Novel Approach to Assess the Role of Oxidative Stress for the Development of Nitrate Tolerance
Andreas Daiber, Matthias Oelze, Silke Sulyok, Meike Coldewey, Eberhard Schulz, Nicolai Treiber, Ulrich Hink, Alexander Mülsch, Karin Scharffetter-Kochanek and Thomas Münzel

Molecular Pharmacology September 2005, 68 (3) 579-588; DOI: https://doi.org/10.1124/mol.105.011585
Open Access
MG53: Biological Function and Potential as a Therapeutic Target
Yan Zhang, Hong-Kun Wu, Fengxiang Lv and Rui-Ping Xiao

Molecular Pharmacology September 2017, 92 (3) 211-218; DOI: https://doi.org/10.1124/mol.117.108241
You have access
Gabapentin Is a Potent Activator of KCNQ3 and KCNQ5 Potassium Channels
Rían W. Manville and Geoffrey W. Abbott

Molecular Pharmacology October 2018, 94 (4) 1155-1163; DOI: https://doi.org/10.1124/mol.118.112953
You have access
Halogenated Ether, Alcohol, and Alkane Anesthetics Activate TASK-3 Tandem Pore Potassium Channels Likely through a Common Mechanism
Anita Luethy, James D. Boghosian, Rithu Srikantha and Joseph F. Cotten

Molecular Pharmacology June 2017, 91 (6) 620-629; DOI: https://doi.org/10.1124/mol.117.108290
You have access
Drugs and Scaffold That Inhibit Cytochrome P450 27A1 In Vitro and In Vivo
Morrie Lam, Natalia Mast and Irina A. Pikuleva

Molecular Pharmacology February 2018, 93 (2) 101-108; DOI: https://doi.org/10.1124/mol.117.110742
You have access
The Role of ACKR3 in Breast, Lung, and Brain Cancer
Maria Neves, Amos Fumagalli, Jelle van den Bor, Philippe Marin, Martine J. Smit and Federico Mayor

Molecular Pharmacology December 2019, 96 (6) 819-825; DOI: https://doi.org/10.1124/mol.118.115279
Open Access
CDK5 Inhibitor Downregulates Mcl-1 and Sensitizes Pancreatic Cancer Cell Lines to Navitoclax
Smit Kour, Sandeep Rana, Jacob I. Contreras, Hannah M. King, Caroline M. Robb, Yogesh A. Sonawane, Mourad Bendjennat, Ayrianne J. Crawford, Carter J. Barger, Smitha Kizhake, Xu Luo, Michael A. Hollingsworth and Amarnath Natarajan

Molecular Pharmacology October 2019, 96 (4) 419-429; DOI: https://doi.org/10.1124/mol.119.116855
You have access
Fevipiprant (QAW039), a Slowly Dissociating CRTh2 Antagonist with the Potential for Improved Clinical Efficacy
David A. Sykes, Michelle E. Bradley, Darren M. Riddy, Elizabeth Willard, John Reilly, Asadh Miah, Carsten Bauer, Simon J. Watson, David A. Sandham, Gerald Dubois and Steven J. Charlton

Molecular Pharmacology May 2016, 89 (5) 593-605; DOI: https://doi.org/10.1124/mol.115.101832
You have access
Dynamin Functions and Ligands: Classical Mechanisms Behind
Mahaveer Singh, Hemant R. Jadhav and Tanya Bhatt

Molecular Pharmacology February 2017, 91 (2) 123-134; DOI: https://doi.org/10.1124/mol.116.105064

Main menu

User menu

Search

Most read article(s)

Pages

Navigate

More Information

ASPET's Other Journals